Stockreport

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024 [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF 2 CALLIPER and CALVID-1 trials of vidofludimus calcium the company will present at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Foru [Read more]